Salvage Resection of Mediastinal Nonseminomatous Germ Cell Tumor in a Patient with Extrathoracic Involvement upon Progression following High-Dose Chemotherapy
Primary mediastinal nonseminomatous germ cell tumor with extrathoracic metastases is associated with a very high mortality rate, and there is no consensus regarding optimal upfront therapy. Once patients fail the first-line treatment, salvage therapy often fails to effectively control the disease. R...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2021-08-01
|
Series: | Case Reports in Oncology |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/518401 |
id |
doaj-c956e1e23a644fd186b91dc9de7e9d22 |
---|---|
record_format |
Article |
spelling |
doaj-c956e1e23a644fd186b91dc9de7e9d222021-09-16T08:40:56ZengKarger PublishersCase Reports in Oncology1662-65752021-08-011421254126010.1159/000518401518401Salvage Resection of Mediastinal Nonseminomatous Germ Cell Tumor in a Patient with Extrathoracic Involvement upon Progression following High-Dose ChemotherapyJia-Ling Chou0David Tse1Medical Oncology, Southern California Permanente Medical Group, Woodland Hills, CA, USAThoracic Surgery, Northwest Permanente, Mt Talbert Medical Office, Clackamas, OR, USAPrimary mediastinal nonseminomatous germ cell tumor with extrathoracic metastases is associated with a very high mortality rate, and there is no consensus regarding optimal upfront therapy. Once patients fail the first-line treatment, salvage therapy often fails to effectively control the disease. Resection of the residual mediastinal mass does not appear to achieve long-term control in those who have extrathoracic metastases following conventional first-line systemic therapy. We report a case where a young man presented with symptomatic brain metastases as well as extensive visceral involvement of the liver, small intestine, and lungs. He was successfully managed with multimodality treatment including high-dose chemotherapy with hematopoietic stem cell support following standard first-line chemotherapy, resection of mediastinal disease, lung metastasectomy, and stereotactic brain radiation. He has achieved long-term survival.https://www.karger.com/Article/FullText/518401mediastinal massgerm cell tumorhigh-dose chemotherapysalvage resection |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jia-Ling Chou David Tse |
spellingShingle |
Jia-Ling Chou David Tse Salvage Resection of Mediastinal Nonseminomatous Germ Cell Tumor in a Patient with Extrathoracic Involvement upon Progression following High-Dose Chemotherapy Case Reports in Oncology mediastinal mass germ cell tumor high-dose chemotherapy salvage resection |
author_facet |
Jia-Ling Chou David Tse |
author_sort |
Jia-Ling Chou |
title |
Salvage Resection of Mediastinal Nonseminomatous Germ Cell Tumor in a Patient with Extrathoracic Involvement upon Progression following High-Dose Chemotherapy |
title_short |
Salvage Resection of Mediastinal Nonseminomatous Germ Cell Tumor in a Patient with Extrathoracic Involvement upon Progression following High-Dose Chemotherapy |
title_full |
Salvage Resection of Mediastinal Nonseminomatous Germ Cell Tumor in a Patient with Extrathoracic Involvement upon Progression following High-Dose Chemotherapy |
title_fullStr |
Salvage Resection of Mediastinal Nonseminomatous Germ Cell Tumor in a Patient with Extrathoracic Involvement upon Progression following High-Dose Chemotherapy |
title_full_unstemmed |
Salvage Resection of Mediastinal Nonseminomatous Germ Cell Tumor in a Patient with Extrathoracic Involvement upon Progression following High-Dose Chemotherapy |
title_sort |
salvage resection of mediastinal nonseminomatous germ cell tumor in a patient with extrathoracic involvement upon progression following high-dose chemotherapy |
publisher |
Karger Publishers |
series |
Case Reports in Oncology |
issn |
1662-6575 |
publishDate |
2021-08-01 |
description |
Primary mediastinal nonseminomatous germ cell tumor with extrathoracic metastases is associated with a very high mortality rate, and there is no consensus regarding optimal upfront therapy. Once patients fail the first-line treatment, salvage therapy often fails to effectively control the disease. Resection of the residual mediastinal mass does not appear to achieve long-term control in those who have extrathoracic metastases following conventional first-line systemic therapy. We report a case where a young man presented with symptomatic brain metastases as well as extensive visceral involvement of the liver, small intestine, and lungs. He was successfully managed with multimodality treatment including high-dose chemotherapy with hematopoietic stem cell support following standard first-line chemotherapy, resection of mediastinal disease, lung metastasectomy, and stereotactic brain radiation. He has achieved long-term survival. |
topic |
mediastinal mass germ cell tumor high-dose chemotherapy salvage resection |
url |
https://www.karger.com/Article/FullText/518401 |
work_keys_str_mv |
AT jialingchou salvageresectionofmediastinalnonseminomatousgermcelltumorinapatientwithextrathoracicinvolvementuponprogressionfollowinghighdosechemotherapy AT davidtse salvageresectionofmediastinalnonseminomatousgermcelltumorinapatientwithextrathoracicinvolvementuponprogressionfollowinghighdosechemotherapy |
_version_ |
1717378345183739904 |